Default company panoramic image
Logo

TNG Pharmaceuticals

FlyVax is a revolutionary and patented cattle vaccine that alleviates the $1 billion of economic pain caused by the bloodsucking horn fly.

  • Stage Prototype Ready
  • Industry Other
  • Location Louisville, KY, USA
  • Currency USD
  • Founded June 2011
  • Employees 3
  • Website flyvax.com

Company Summary

TNG Pharmaceuticals, a Louisville, KY based company is furthering the development of a patented vaccine, FlyVax. It is designed for the vaccination of cattle to specifically disrupt bloodfeeding by horn flies, the most economically important pest of livestock in the United States and much of the world. FlyVax is intended to significantly increases beef and dairy production and will be sold through veterinarians.

Team

  • Default avatar
    Serge Martinod
    CEO

    Serge Martinod, DVM, PhD MBA - CEO and CSO
    20 years of experience in biological and pharmaceutical product development. for animal health (Pfizer, SmithKline Beecham and Novartis)
    12 years of experience in managing VC funded start-ups for animal health

  • Default avatar
    Phoebe Wood
    Executive Chair

    Phoebe Wood, MBA - Executive Chair
    Former CFO of Brown-Forman; board member of Coca-Cola Enterprises, Invesco, and Leggett & Platt; Trustee of the University of Louisville

Advisors

  • Default avatar
    Bill Strench & Joe Miller - Frost Brown Todd
    Lawyer
    Unconfirmed

Previous Investors

  • Default avatar
    OWL Angel group
    Unconfirmed
    Default avatar
    GOOSE Society - (Grand order of successful entrepreneurs)
    Unconfirmed
    Default avatar
    CompaniesWood
    Unconfirmed